Why is healthcare so much more expensive in the US than in other wealthy countries?

Healthcare costs in the United States are significantly higher than in other wealthy nations due to a combination of systemic and structural factors rather than a single cause. Experts generally point to several key drivers:

• Higher Prices for Services and Goods: The primary driver is that the U.S. pays much more for the same medical services, procedures, and prescription drugs. Hospitals and providers negotiate rates that are often several times higher than those in countries with government-regulated pricing.
• Administrative Complexity: The U.S. system involves a fragmented network of private insurers, each with its own billing requirements, paperwork, and networks. This creates massive administrative overhead for hospitals and clinics, which must employ large staffs just to manage claims and billing—costs that are largely absent in streamlined, single-payer or centralized systems abroad.
• Market-Based Pricing and Lack of Regulation: Unlike most other wealthy countries, the U.S. government does not broadly negotiate or cap the prices of pharmaceuticals or hospital procedures. This allows manufacturers and providers to set market-clearing prices that are often not constrained by the cost-effectiveness thresholds used elsewhere.
• Fee-for-Service Model: Much of the U.S. healthcare system rewards the volume of care rather than the quality or outcome of care. Providers are often paid for every test, scan, or procedure they perform, which can create financial incentives to increase the intensity of treatment regardless of whether it leads to better patient outcomes.
• High Costs of Healthcare Workers: Physicians and other medical professionals in the U.S. generally receive significantly higher compensation than their counterparts in Europe or Canada, which contributes to the overall cost of delivering care.
• The Role of Profit: Many components of the U.S. system, including private insurance companies, pharmaceutical manufacturers, and for-profit hospital systems, operate under models that prioritize or require profit margins, which are factored into the final price of healthcare services.

While Americans pay significantly more, studies consistently show that this spending does not consistently translate into better health outcomes, such as life expectancy or lower rates of chronic disease, compared to other wealthy nations.